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Review
The rare donor program at Western Province Blood 
Transfusion Service (WPBTS) is a regional rare donor 
program established in 1986. In collaboration with the South 
African National Blood Service (SANBS), rare donors are 
phlebotomized for use of their collected units both locally 
and internationally. Units are stored frozen at a single storage 
facility within SANBS in Durban. SANBS manages the frozen 
inventoried units. Rare units in the liquid state are managed 
by their respective centers. The International Blood Group 
Reference Laboratory liaises with SANBS; WPBTS receives 
international requests from SANBS and ships the liquid unit 
to the client when needed if it is more practical.
The number of active rare donors at WPBTS is 119. There 
were 71 new rare donors added between 2012 and 2014. These 
consisted of donors lacking high-prevalence antigens. Most of 
the active rare donors have phenotypes with Fy(a–b–), s–, and 
Jk(b–) combinations. These donors were identified through 
screening efforts at WPBTS.
Shipments
When SANBS has insufficient stock or a liquid blood unit 
is required, the WPBTS is approached to fulfill the request. 
WPBTS has shipped Rhnull units to Ireland, Canada, and 
Australia when a liquid unit was requested. At WPBTS, we do 
not normally ship frozen rare units internationally, as our rare 
donor units are stored frozen within SANBS (as noted earlier) 
for international use.
In the timeframe of 2012–2014, there were 46 rare units 
shipped domestically and 9 shipped internationally. 
Incentives for Rare Donors
Our rare donors (Table 1) are invited to the annual Donor 
Long Service Awards evening, where they are honored for their 
contribution. They are phlebotomized at their place of work or 
home when required to do so, i.e., in cases of emergency when 
they are unable to attend one of our fixed site or mobile clinics 
because of their time constraints. Carepacks are provided 
for impoverished donors. These carepacks consist of general 
household provisions. They are not used as incentives and are 
provided to donors that are seen to be underprivileged.
WPBTS has two Rhnull donors. The genetic background 
of one donor is GA-154_157delCCTCins GA; the genetic 
background of the other is not known.
Transfusion Reactions
The following describes a case of an HrS– patient with anti-
HrS who received 2 emergency units in 2012. No transfusion 
reaction was observed or reported.
In January 2012, a pregnant woman from Nigeria 
delivered her baby in Cape Town. At the time of her delivery, 
she received 2 units of group O, D– random emergency blood. 
No pre-transfusion immunohematologic tests were performed, 
as this was an emergency situation. Samples were then sent for 
antibody screens and, because no further blood was required, 
the patient was discharged after a vaginal delivery and sent 
Table 1. Summary of rare donors at Western Province Blood 
Transfusion Service in South Africa as of November 2015
Phenotype ABO group Number of donors Donation status 
C– E– K– Fy(a–b–) Jk(b–) 
S– (GATA mutation)
O 76 Active
hrB– (RH:–31) O 10 Active
k– O 10 Active
C– E– K– Fy(a–b–) Jk(b–) 
s– (GATA mutation)
O 5 Active
U– O 4 Active
B 1 Not active
HrB– (RH:–34) O 4 (3 are sisters) Active
hrS– (RH:–19) O 3 Active
Jo(a–) O 2 Active
Oh (Bombay) Oh 1 Active
Rhnull O 1 Active
A 1 Active
Gerbich null O 1 Not active
A 1 Not active
Lu(b–) O 1 Active
Js(b–) O 1 Active
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home with her baby. She was readmitted a few days later, as 
she had a massive bleed and was anemic. Samples were then 
sent with a request for crossmatched blood. The results of 
the antibody screens were as follows: antibody screens were 
positive in enzyme and in antihuman globulin (AHG) media 
utilizing an automated gel test system (Serascan Diana 3 and 
Serascan Diana 3P, Grifols, Barcelona, Spain). The test results 
demonstrated anti-E reacting 3+ and 4+, respectively. Our 
in-house WPBTS panel (utilizing the tube method) showed 
antibodies with Rh specificity (yielding results 1+ and 2+ 
macro at room temperature, 37°C, and AHG readings). 
Anti-HrS was suspected and confirmed by the SANBS 
Reference Laboratory, and the patient was typed as HrS–. No 
transfusion reaction was noted during or after the infusion of 
the emergency blood. After the identification of the antibody, 
the patient received compatible blood—1 unit from the SANBS 
Rare Donor File and 1 unit later from her brother (identified 
during the family study). One year later, the patient enrolled 
as a rare blood donor. She has donated for two local patients. 
Immigration issues for these donors are dynamic, and this 
causes them to be difficult to locate. In addition, regulations for 
donation after travel to malarial zones postpone donation for 3 
years; the former patient visits her home at least every 2 years, 
making donation nearly impossible. Her brother does not visit 
home very often, but other factors cause him to be periodically 
deferred from donating for 6-month increments. 
Rare donors are important to keep in the system, and 
the immunohematology laboratories in South Africa work 
intensely to keep track of their rare donors.
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